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Abstract
Escherichia coli is usually a commensal bacterium of humans and animals. Pathogenic variants cause 
intestinal and extra intestinal infections, including gastroenteritis, urinary tract infection, meningitis, peritonitis 
and septicemia. Nowadays, the worldwide concern on the spread of this bacterium is mainly connected to the 
resistance phenomenon. This research was conducted in order to reveal antimicrobial resistance patterns in 
Escherichia coli, causing human illness.
A total of 30 Escherichia coli isolates were recovered from patients hospitalized with food-borne infections, 
during June 2013-May 2014. The majority of the patients declared the consumption of undercooked meat products 
(especially beef), raw milk and soft cheeses. The isolates were tested through polymerase chain reaction (PCR) for 
identiϐication and conϐirmation of pathogenicity and further, for antimicrobial susceptibility to 26 antimicrobials, 
using the classical disk diffusion method. 
All isolates were Shiga Toxin-producing Escherichia coli (STEC). All isolates proved to be resistant to at least 
one antimicrobial agent. Resistance was most frequently observed to ampicillin, amoxicillin and clavulanic acid, 
ceftazidime, cefepime and norϐloxacin.
Our ϐindings demonstrate that Shiga Toxin-producing Escherichia coli recovered from hospitalized patients 
and presumably of animal origin is highly resistant to critically important antimicrobials for human medicine. 
These data support the ongoing concern regarding antimicrobial resistance, antimicrobial use in veterinary and 
human medicine and nevertheless, the problem of antimicrobial resistance in the food chain.
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INTRODUCTION
Escherichia coli (E.coli) are the most prevalent 
bacteria in animals and humans and are also an 
important zoonotic agent, which can be implicated 
in animal and human infectious diseases (Costa et 
al., 2008). In humans, E.coli can cause a variety 
of intestinal and extra-intestinal infections, such 
as diarrhea, urinary tract infection, meningitis, 
peritonitis, septicemia and gram-negative bacterial 
pneumonia (Hammerum and Heuer, 2013). 
Based on virulence properties, enteric 
E.coli are classiϐied into enterotoxigenic (ETEC), 
enteropathogenic (EPEC), enteroinvasive (EIEC), 
verotoxigenic or Shiga toxin-producing E.coli 
(VTEC or STEC), enterohemorrhagic (EHEC) and 
enteroaggregative (EAEC), all being causative 
agents of diarrhea.
STEC represents a major cause of 
gastroenteritis that may be complicated by 
haemorrhagic colitis, or the hemolytic-uremic 
syndrome, which is the main cause of acute renal 
failure in children (Mora et al., 2005).
E.coli 0157:H7, which belongs to STEC group 
is the most common serotype isolated from 
individuals with haemorrhagic colitis. Outbreaks 
of infection with those bacteria have emerged 
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due to the consumption of contaminated animal-
derived food products (Belongia et al., 1991).
Contaminated food, especially undercooked 
ground beef, unpasteurized (raw) milk, soft 
cheeses made of raw milk and even raw fruits 
and vegetables (such as sprouts) are considered 
important sources of E.coli infection.
Meat and meat products can be easily 
contaminated by E.coli during animal evisceration 
after slaughter, through contact with tainted water 
or during meat handling (Alvarez-Fernandez et al., 
2013).
Antimicrobial agents are widely used not 
only in human medicine but also in food animal 
production; therefore, meat is frequently 
contaminated with antimicrobial resistant 
bacteria, including E.coli. 
Humans can be colonized with E.coli of animal 
origins, and because of resistance to commonly 
used antimicrobial agents, these bacteria may 
cause infections for which limited therapeutic 
options are available (Hammerum and Heuer, 
2013).
Furthermore, foods contaminated with 
antibiotic resistant bacteria could be a major threat 
to public health, as there is the distinct possibility 
that genes encoding antibiotic resistance 
determinants that are carried on mobile genetic 
elements may be transferred to other bacteria of 
human clinical signiϐicance (Van et al., 2008).
In Romania, like in many other developing 
countries, antimicrobial resistance epidemiology 
is still in development and little is known about 
the potential role of contaminated food (especially 
meat and meat products) in the dissemination of 
multidrug-resistant E.coli, because very limited 
research works had been carried out in our 
country concerning these aspects.
This study was conducted in order to reveal 
antimicrobial resistance patterns of E.coli of 
presumably animal origin, causing human illness.
MATERIALS AND METHODS
A total of 30 E.coli isolates recovered from 
patients hospitalized with food-borne infections 
at the Hospital of Infectious Diseases from Cluj-
Napoca, between June 2013-May 2014 were 
examined. The strains were isolated mainly from 
patients with diarrhea. The majority of the patients 
declared the consumption of undercooked meat 
products (especially beef), raw milk and soft 
cheeses. 
1. Detection of Shiga toxin-producing genes 
The isolates were tested through polymerase 
chain reaction (PCR) with primers speciϐic for the 
genes encoding Stx1 and Stx2 toxins (stx1 and 
stx2 genes).
1.1 DNA extraction 
The DNA extraction protocol followed the steps 
previously reported by Lapusan (2012). Brieϐly, 
2-3 presumptive E.coli colonies were chosen and 
immersed in 150 μl Chelex solution (Germany). 
The Eppendorf tubes were afterwards subjected 
to high-degree temperatures for cell membrane 
lysis, releasing the DNA, which was quantiϐied on 
a Nanodrop ND-1000 spectrophotometer analyzer 
(NanoDrop Technologies, Inc., Wilmington, DE, 
USA).
1.2 The PCR method
The PCR reaction mix (25 μl) comprised: 1X 
PCR green Buffer, 2.5 mM MgCl2, 5 pmol of each 
primer, dNTPs each at 200 μM, 2.5 U of Taq DNA 
Polymerase (Promega, Madison, WI, USA) and 100 
ng of genomic DNA. PCR was performed under the 
following conditions: 940C for 3 min followed by 
35 cycles of 940C for 30 sec, 600C for 30sec, 720C 
for 1 min and a ϐinal extension step of 720C for 7 
min. 
The primers used for the detection of Shiga 
toxin-producing genes were previously reported 
by Tahamtan et al. (2010).
2. Antibiotic susceptibility tests
A number of 26 antimicrobials, some co-
mmonly used in veterinary medicine and some 
mainly employed in humans, were tested on the 
E.coli isolates, using the classical disk diffusion 
method, according to the guidelines of the Clinical 
and Laboratory Standards Institute (CLSI)  (CLSI, 
2006). The isolates were tested against ampicillin, 
cefotaxime, ceftazidime, ciproϐloxacin, nalidixic 
acid, tetracycline, trimethoprim/sulfamethoxazole, 
amoxicillin and clavulanic acid, chloramphenicol, 
gentamicin, piperacillin, cefazolin, cefoxitin, 
cefepime, amikacin, norϐloxacin, nitrofurantoin, 
cefuroxime, tobramycin, ceϐixime, cefoperazone, 
imipenem, meropenem, entopenem, levoϐloxacin 
and fosfomycin. The CLSI breakpoints were applied 
for the interpretation of the results.
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RESULTS AND DISCUSSIONS
A number of 30 E.coli isolates recovered from 
patients hospitalized with food-borne infections 
at the Hospital of Infectious Diseases from Cluj-
Napoca, were tested for Shiga toxin-producing 
genes through PCR and also for antimicrobial 
susceptibility to 26 antimicrobial agents, some 
commonly used in veterinary medicine and some 
mainly employed in humans, by using the classical 
disk diffusion method.
All isolates included in this study carried Shiga 
toxin-producing genes. PCR showed that 8 isolates 
(26.66%) carried stx1 genes, 16 (53.33%) carried 
stx2 genes, while 6 (20%) isolates possessed both 
stx1 and stx2 genes. 
The analyzed E.coli isolates proved to be 
highly resistant to antimicrobials. All isolates 
showed resistance to more than one antimicrobial. 
Overall, resistance was frequently observed to 
ampicillin (60.66%), nalidixic acid (56.66%) 
and norϐloxacin (56.66%). The E.coli isolates 
included in the study also displayed resistance to 
ciproϐloxacin, tetracycline, gentamicin, cefuroxime, 
cefotaxime, ceftazidime, ceϐixime, nitrofurantoin, 
trimethoprim/sulfamethoxazole and piperacillin. 
A lower resistance rate was observed to cefoxitin, 
amikacin and chloramphenicol. All isolates proved 
to be susceptible to imipenem, meropenem and 
entopenem (Tab. 1).
The emergence and dissemination of antimi-
crobial resistance among Shiga toxin-producing 
E.coli may have potential negative clinical impli-
cations.
The World Health Organization (WHO) publi-
shed a report regarding the critically important 
antimicrobials for human medicine. According 
to the report, third and fourth generation 
cephalosporins, as well as quinolones and 
amynoglicosides are considered to be critically 
important antimicrobials in the treatment of 
human E.coli infections (World Health Organiza-
tion, 2007). Moreover, in the case of E.coli, 
ϐirst and second generation cephalosporins as 
well as sulfonamides are regarded as highly 
important antimicrobials for the treatment of 
E.coli infections in humans. According to our 
study a high percentage of the isolates proved to 
be highly resistant to third and fourth generation 
cephalosporins (cefotaxime, ceftazidime, cefe-
pime, ceϐixime, cefoperazone) and also to quinolo-
nes (nalidixic acid) and ϐluoruoquinolones (cipro-
ϐloxacin, norϐloxacin, levoϐloxacin).
Fluoroquiolones are critically important for 
treating serious infections in humans (Van et 
al., 2008). Treatment of serious human enteric 
infections with an effective ϐluoroquinolone can 
reduce the duration of illness, and most likely 
prevent complications and adverse outcomes 
including hospitalization (FDA, 2000). Therefore, 
resistance to ϐluoroquinolones can be considered 
an important public health concern.
A high resistance rate was observed to 
gentamicine, an amynoglicoside which is also 
Tab. 1. Percentage of E.coli isolates resistant to 
different antimicrobials 
Antimicrobials
Percentage of 
resistance
Ampicillin 60.66
Cefotaxime 33.33
Ceftazidime 33.33
Ciproϐloxacin 40
Nalidixic acid 56.66
Tetracycline 40
Trimethoprim/
sulfamethoxazole
33.33
Amoxicillin and clavulanic acid 50
Chloramphenicol 6.66
Gentamicin 40
Piperacillin 33.33
Cefazolin 13.33
Cefoxitin 6.66
Cefepime 23.33
Amikacin 6.66
Norϐloxacin 56.66
Nitrofurantoin 16.66
Cefuroxime 40
Tobramycin 23.33
Ceϐixime 33.33
Cefoperazone 23.33
Imipenem 0
Meropenem 0
Entopenem 0
Levoϐloxacin 23.3
Fosfomycin 23.33
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included in the list of critically important anti mi-
crobials for human therapy. In humans, gentamicin is 
used in association with β-lactams, for the treatment 
of severe infections like sepsis or endocarditis.
The highest resistance rate was observed to 
ampicillin, an antibiotic frequently administered 
in both human and veterinary medicine.
Even if the origin of E.coli that caused the 
infections has not been properly investigated, it 
was assumed that it must have been an alimentary 
one, given the fact that the majority of the patients 
declared the consumption of undercooked meat 
products (especially beef), raw milk or soft cheeses.
In many cases, the origin of E.coli that cau-
se infection in humans remains unknown, and 
the signiϐicance of the animal reservoir of the 
antimicrobial resistant E.coli has not been 
quantiϐied. However, treatment options in humans 
are compromised if the causative bacteria are 
already resistant to commonly used antimicrobial 
agents (Hammerum and Heuer, 2013).
Moreover, it is a well known fact that foods 
contaminated with antibiotic resistant bacteria 
could be a major threat to public health, as there 
is the distinct possibility that genes encoding 
antibiotic resistance determinants that are carried 
on mobile genetic elements may be transferred to 
other bacteria of human clinical signiϐicance (Van 
et al., 2008). E.coli is a candidate vehicle for such 
transfer because of its diversity and also because 
it survives as common ϐlora in the gastrointestinal 
tracts of both humans and animals. They are 
sensitive to selection pressure exerted by 
antibiotic usage and carry genetic mobile elements 
to achieve such transmission (Van den Bogaard et 
al., 2000).
The presence of pathogenic and non-patho-
genic E.coli isolated from food and food products 
and resistant to different antimicrobials has been 
previously reported by many authors (Van et al., 
2008; Saenz et al., 2004; Pavithra et al., 2013; Sala 
et al., 2012; Karadal et al., 2013; Hosseini et al., 
2013, Colobatiu et al., 2014). 
In a previous study we’ve analyzed E.coli 
isolations for antimicrobial resistance genes. The 
results of the study proved that E.coli isolates 
recovered from raw poultry meat are highly 
resistant to antimicrobials and carry antimicrobial 
resistance genes that could be transferred to other 
microbes in the food chain, even important human 
pathogens (Colobatiu et al., 2014).
The isolates included in our study proved to 
be resistant to a large number of antimicrobial 
agents, some of them being commonly used in the 
prophylaxis or treatment of infections in human 
as well as in veterinary medicine. The widespread 
non-human use of antimicrobial agents, some of 
them regarded as critically or highly important 
for human therapy, creates a reservoir of 
resistant bacteria or resistance genes that may 
be transferred to humans, adding to the burden 
of antimicrobial resistance in human medicine 
(Hammerum and Heuer, 2013). 
CONCLUSIONS
This study was conducted in order to reveal 
antimicrobial resistance patterns of E.coli of 
presumably animal origin, causing human illness.
Our ϐindings demonstrate that Shiga Toxin-
producing E.coli, presumably of animal origin and 
recovered from hospitalized patients, is highly 
resistant to critically important antimicrobials 
for human medicine. These data support the on-
going concern regarding antimicrobial resistance, 
antimicrobial use in veterinary and human me-
dicine and nevertheless, the problem of antimi-
crobial resistance in the food chain.
Our ϐindings provide a baseline data for fur-
ther epidemiological studies which lack in infor-
ma tion regarding our country. 
We underline the necessity of the implementa-
tion of a national antimicrobial resistance moni-
toring programme. 
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